Ahmed Alanazi, Head of Hematology/Oncology Clinical Pharmacy Section at King Fahad Medical City – KFMCK, shared a post on X:
”7yrs update from CROWN Trial
55% vs 3% lorlatinib vs crizotinib and mPFS still not reached! vs 9.1 months
From 2nd year to 7yrs only 15% progressed!
Impressive result continues with CROWN.”
Other Articles Featuring Ahmed Alanazi On OncoDaily.